EnteroBiotix has completed enrolment of patients in a Phase 2 double-blind, placebo-controlled, multi-centre clinical study in irritable bowel syndrome (IBS) and is progressing a Phase 2a study with ...

Adopting a healthy lifestyle could reduce the risk of irritable bowel syndrome, or IBS, a new study found ... Participants who exhibited one behavior had a 21% lower risk of developing IBS symptoms ...

Newsweek spoke with three doctors about the rising rates of colorectal cancer in young people and the lifestyle changes that ...

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...